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enetics of
ilated Cardiomyopathy
ore Genes That Kill*
effrey A. Towbin, MD, FACC,†
. John Solaro, PHD‡
ouston, Texas; and Chicago, Illinois
ilated cardiomyopathy (DCM), characterized by left ven-
ricular dilation and systolic dysfunction, is the most com-
on form of heart muscle disease, comprising 60% of the
ases of identified cardiomyopathies (1). The disorder is
linically heterogeneous, ranging from affected individuals
ith clinical presentations of severe symptoms, including
eart failure, sudden death, or resuscitated sudden death, to
symptomatic individuals. The underlying etiologies of
CM include ischemic heart disease, acquired disease
aused by viral infection or cardiac toxins, metabolic disor-
ers, and genetic causes. In the latter case, 30% to 40% of
atients with DCM have a familial form of DCM.
See page 2033
Over the past decade, genetic heterogeneity in DCM has
een demonstrated, and many of the causative genes have
een identified. These genes appear to encode mutant
roteins of the cytoskeleton, sarcolemma, and sarcomere
1), and we previously speculated that the linkage of the
arcolemma, cytoskeleton, and sarcomere would comprise
he “final common pathway” of DCM (2).
Little in the way of genotype-phenotype correlations have
een published for familial DCM, in part due to the “private
utation” nature of the genes identified and the relatively
mall number of mutations in any one gene. However,
valuation of the patients and families described as having
enetic mutations to date have commonly had severe out-
omes. Because DCM is the most common diagnosis
equiring heart transplantation and has been reported to
esult in a 50% five-year mortality rate, it is not surprising
hat many of the patients studied have poor outcomes.
hether or not the mutated genes identified typically result
n a poor prognosis or there is selection bias has not been
larified.
In the study reported by Mogensen et al. (3) in this issue
f the Journal, mutations in the genes encoding the sarco-
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.m
From the †Baylor College of Medicine, Houston, Texas; and the ‡University of
hicago, Chicago, Illinois.eric proteins troponin C (TnC) and troponin T (TnT)
ere identified in five families with inherited DCM, includ-
ng one family with troponin C (TNNC1) mutations and
our families with troponin T (TNNT2) mutations. In the
amilies studied, penetrance was 100% and the outcomes
ere poor, with nine deaths in the 21 gene carriers (43%),
ncluding five from heart failure and four with sudden death.
n these patients, the mean age at death was 29 years.
nother six patients underwent transplantation (29%), with
he remaining patients appearing stable while receiving
ong-term therapy. The authors suggest that mutations in
hese genes are poor prognostic indicators. Functional
tudies using the two-hybrid luciferase assay to determine
he effects of mutations on sarcomere function suggest that
lterations in troponin interactions occur, leading to altered
egulation of myocardial contractility.
Several points should be raised. The youngest affected
ndividuals reported were 16 years of age, with none
pparently developing disease during early life. Is this due to
election bias, lack of early evaluation, or age-dependent
nset due to the need for long-standing mechanical stress?
ow does the contractile apparatus abnormality lead to the
linical phenotype, and what is the mechanism of sudden
eath?
Several possibilities exist. These possibilities reflect not
nly the highly ordered and interactive network of proteins
hat make up the cardiac sarcomere and determine the force
nd shortening capability of the myocardium, but also the
ole of sarcomeric proteins in Ca2 homeostasis. Troponin
is the major Ca2 buffer in the cardiac myocyte, and it is
mportant to understand that the affinity of cardiac troponin
(cTnC) for Ca2 is not a constant. Changes in the ability
f TnC to bind and/or hold on to Ca2 would be expected
o affect intracellular Ca2. Troponin C Ca2 affinity is
egulated by the state of other thin-filament proteins (e.g.,
hosphorylation of cardiac troponin I [cTnI]), which lowers
he affinity, and by force-generating cross-bridges, which
ncreases the affinity. The latter is a significant factor in
tarling’s law, in which it appears that increases in length,
hich are associated with an increased number of cross-
ridges reacting with the thin filament, also increase the
ffinity of TnC for Ca2 and determine the slope of the
entricular end-systolic pressure-volume relationship (4).
Regions of TnT and TnC affected by the DCM muta-
ions reported by Mogensen et al. (3) are critical to
rotein-protein interactions that signal activation of the
ctin–cross-bridge reaction. These interactions are trig-
ered by Ca2 binding to TnC, but are fully elaborated and
ustained by feedback effects of force-generating cross-
ridge interactions with the thin filaments (4). The binding
f cross-bridges to the thin filament promotes the binding
f near-neighbor cross-bridges and the cooperative spread
f activation laterally along the thin filament. Moreover, as
entioned earlier, strong force-generating interactions of
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Editorial Comment November 16, 2004:2041–3he cross-bridges with the thin filament induce an increase
n the affinity of TnC for Ca2 (4).
Although most of the mutations described in the report
y Mogensen et al. (3) have not been thoroughly tested with
egard to effects on myofilament function, the deletion
utation cTnT K210 has been reported to induce a
epression in the myofilament response to Ca2 (5). It is
ikely that the same effect occurs with the R205L mutation.
he region surrounding K210 and R205 has been demon-
trated to be critical in the control of the myofilament
esponse to Ca2. Protein kinase C (PKC)-dependent
hosphorylation of a T203, T203E, or T203A mutation
nduces a significant depression in the maximum tension
nd a decrease in myofilament sensitivity to Ca2 (6).
oreover, these changes also induce a decrease in filament
liding velocity, suggesting that afterload velocity of con-
raction would be reduced, leading to a reduction in power.
rotein kinase C is activated in heart failure (4), and it will
e of interest to determine whether the mutations linked to
CM are exacerbated with PKC-dependent phosphoryla-
ion of nearby residues. The region surrounding K210 is
ocalized in the N-cap of a TnT-alpha helix, and molecular
odeling has indicated that modification in this N-cap
ould induce large structural modifications likely to be of
ignificance in transmission of the cTnC Ca2-binding
ignal to tropomyosin (Tm) (6). The result is a systolic
bnormality that would contribute significantly to mainte-
ance of cardiac output at elevated end-diastolic volumes,
bnormal stretching of the myocardium, and altered gene
xpression (4). These alterations, which are secondary to the
rimary defect in the sarcomere, are likely to alter Ca2
uxes and be critical in the course of the syndrome, leading
o sudden death. Triggered arrhythmias are generated by
ltered Ca2 fluxes and delayed afterdepolarizations
DADs). Important factors include alterations in Na/Ca
xchange activity and depression in IK1, the outward current
ccurring mainly during the resting membrane potential (7).
t is apparent, however, that these same alterations may be
irectly related to mutations in the sarcomere and their
ffects on cellular Ca2 fluxes and ionic currents.
Variations in the effects of force-generating cross-
ridges on TnC Ca2 affinity may play a significant role
n triggered arrhythmias in hearts with DCM-linked
utations in thin-filament proteins. The mechanism for
nduction of these arrhythmias involves heterogeneous
xcitation-contraction (EC) coupling in serially coupled
lements of the myocardium (8). Stretches or releases of
elatively inactive regions of the myocardium by adjacent,
ully active regions lead to a release of Ca2 from the
yofilaments. A release of Ca2 from the myofilaments
s known to occur with changes in length that release
ound cross-bridges, thus reducing the affinity of TnC
or Ca2 (8). Triggered, propagated contractions and
a2 waves that occur as a result of the release of
yofilament Ca2 are likely to be accompanied by
ADs, possibly by the effects on electrogenic Na/Ca 3xchange or by nonselective sarcolemmal channels. These
ffects are reminiscent of the triggered arrhythmias oc-
urring in nonischemic heart failure (7). An example of
ow such a mechanism might contribute to DADs is the
bnormality associated with ischemic zones adjacent to
ell-perfused regions of myocardium. In the case of
earts expressing mutant TnT or TnC, if a mosaic exists,
ne might imagine similar regions of heterogeneous EC
oupling with variations in stresses and strains between
egions of the heart expressing mutant and wild-type
roteins, which produces a similar effect. Interestingly,
he mechanical effects induced by ischemia and by ex-
ression of the cTnT-delta K210 mutant are quite similar
n involving a depression in the myofilament response to
a2.
Linkage of the G159D mutation in the C-terminal lobe
f cTnC to DCM is especially interesting in view of its
ovelty and its location in a region that reacts tightly with an
-terminal region of cTnI at amino acids 33 through 80.
he C-terminal lobe of TnC is generally considered to be
tructural in that, unlike the case with the N-terminal lobe,
a2 exchange with the C-terminal lobe is much too slow
o occur within a beat of the heart. However, modulation of
he interactions of this region of TnC with TnI has been
eported to have a significant impact on the force and
hortening of cardiac myofilaments. For example, phos-
horylation of TnI-S43 and -S45 or mutations S43E,
45E, or S43A, S45A all result in a depression maximum
ension (4). Thus, the charge change in the TnC mutation
159D may also modify an interaction of cTnI with cTnC,
eading to a reduction in tension-generating capability,
hortening, and power generation by the heart. The mech-
nism for these changes could be related to a defect in
ransmission of cTnC Ca2 binding to Tm, but also altered
eedback effects of force-generating cross-bridges on the
hin filament. Troponin C G159 appears to comprise a
-cap of the terminal alpha helix of TnC and thus may be
f considerable structural significance. It will be of great
nterest to determine the effects of the G159D mutation of
TnC on the function of the sarcomeric lattice of proteins.
Caution, however, should be maintained regarding
enotype-phenotype correlation interpretations. Many pre-
ious studies on cardiac genetics have suggested “benign” or
malignant” outcomes related to gene mutations (9,10), and
any of these have later been shown to be inconsistent and
onspecific (11). Whether these mutations determine the
utcome or whether the small number of patients and
otential selection bias is responsible for the appearance of
cause and effect relationship remains to be proven.
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